A senior lecturer at the University of New South Wales discussed the use of AI to improve early prognosis and personalized treatment plans for neurodegenerative diseases, cardiovascular imaging and multiomics. The lecture highlighted the potential of AI algorithms to detect subtle changes at early stages through advanced multiomics techniques and medical imaging analysis. The speaker has expertise in analyzing medical images and has collaborated with medical professionals to develop AI tools for diagnosis of cancer, neurodegenerative disease, and heart disease. Why it matters: AI-driven prognosis and treatment planning promises earlier intervention and improved outcomes for challenging diseases in the region.
MBZUAI researchers presented DEFUSE-MS at MICCAI 2025, a novel AI system for analyzing changes in MRI scans of multiple sclerosis (MS) patients. DEFUSE-MS uses a deformation field-guided spatiotemporal graph-based framework to identify new lesions by reasoning about how the brain has changed. The model constructs graphs of small regions within baseline and follow-up MRIs, linking them across time with edges enriched with learned embeddings of the deformation field. Why it matters: DEFUSE-MS reframes the task from simple "spot the difference" to understanding structural changes, potentially improving the speed and accuracy of MS diagnosis and treatment monitoring.
Researchers propose a universal anatomical embedding (UAE) framework for medical image analysis to learn appearance, semantic, and cross-modality anatomical embeddings. UAE incorporates semantic embedding learning with prototypical contrastive loss, a fixed-point-based matching strategy, and an iterative approach for cross-modality embedding learning. The framework was evaluated on landmark detection, lesion tracking and CT-MRI registration tasks, outperforming existing state-of-the-art methods.
This paper introduces BRIQA, a new method for automated assessment of artifact severity in pediatric brain MRI, which is important for diagnostic accuracy. BRIQA uses gradient-based loss reweighting and a rotating batching scheme to handle class imbalance in artifact severity levels. Experiments show BRIQA improves average macro F1 score from 0.659 to 0.706, especially for Noise, Zipper, Positioning and Contrast artifacts.
MBZUAI's BioMedIA lab, led by Mohammad Yaqub, is developing AI solutions for healthcare challenges in cardiology, pulmonology, and oncology using computer vision. Yaqub's previous research analyzed fetal ultrasound images to correlate bone development with maternal vitamin D levels. The lab is now applying image analysis to improve the treatment of head and neck cancer using PET and CT scans. Why it matters: This research demonstrates the potential of AI and computer vision to improve diagnostic accuracy and accessibility of healthcare in the region and beyond.
MBZUAI valedictorian Salma Hassan developed a multimodal graph learning approach for early dementia diagnosis and prognosis. Her master's thesis focused on differential diagnosis to identify specific dementia subtypes and predicting cognitive decline in preclinical patients. The AI model leverages brain imaging, genetics, and clinical records to improve diagnostic accuracy. Why it matters: This research can improve early detection and resource allocation for dementia management, especially in developing countries.
This survey paper reviews recent literature on continual learning in medical imaging, addressing challenges like catastrophic forgetting and distribution shifts. It covers classification, segmentation, detection, and other tasks, while providing a taxonomy of studies and identifying challenges. The authors also maintain a GitHub repository to keep the survey up-to-date with the latest research.